Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms

Janne Lehtiö(Science for Life Laboratory), Taner Arslan(Science for Life Laboratory), Ioannis Siavelis(Science for Life Laboratory), Yanbo Pan(Science for Life Laboratory), Fabio Socciarelli(Science for Life Laboratory), Olena Berkovska(Science for Life Laboratory), Husen M. Umer(Science for Life Laboratory), Georgios Mermelekas(Science for Life Laboratory), Mohammad Pirmoradian(Science for Life Laboratory), Mats Jönsson(Lund University), Hans Brunnström(Lund University), Odd Terje Brustugun(Oslo University Hospital), Krishna Pinganksha Purohit(MRC Centre for Regenerative Medicine), Richard Cunningham(MRC Centre for Regenerative Medicine), Hassan Foroughi Asl(Karolinska University Hospital), Sofi Isaksson(Lund University), Elsa Arbajian(Lund University), Mattias Aine(Lund University), Anna Karlsson(Lund University), Marija Kotevska(Lund University), Carsten Gram Hansen(MRC Centre for Regenerative Medicine), Vilde Drageset Haakensen(Oslo University Hospital), Åslaug Helland(Oslo University Hospital), David Tamborero(Science for Life Laboratory), Henrik J. Johansson(Science for Life Laboratory), Rui M. Branca(Science for Life Laboratory), Maria Planck(Lund University), Johan Staaf(Lund University), Lukas M. Orre(Science for Life Laboratory)
Nature Cancer
November 22, 2021
Cited by 114Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis